Evidence map›Paper›PMID 35204561›Full record

ReviewDiagnostics (Basel, Switzerland)2022

Radiomics Analysis of [

Mirela Gherghe, Alexandra Maria Lazar, Mario-Demian Mutuleanu, Adina Elena Stanciu, Sorina Martin

Abstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Beyond the Primary Tumor: Malignancy Risk and Evaluation Strategies forMolecular imaging and radionuclide therapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mirela GhergheNuclear Medicine Department, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.
Alexandra Maria LazarNuclear Medicine Department, Institute of Oncology "Profesor Doctor Alexandru Trestioreanu", 022328 Bucharest, Romania.ORCID 0000-0003-1832-4719
Mario-Demian MutuleanuNuclear Medicine Department, University of Medicine and Pharmacy Carol Davila Bucharest, 050474 Bucharest, Romania.ORCID 0000-0002-0483-5908
Adina Elena StanciuCarcinogenesis and Molecular Biology Department, Institute of Oncology "Profesor Doctor Alexandru Trestioreanu", 022328 Bucharest, Romania.ORCID 0000-0002-9494-6686
Sorina MartinEndocrinology Department, Elias Emergency University Clinic Hospital, 011461 Bucharest, Romania.ORCID 0000-0001-9622-8883

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe performed a systematic review of the literature to provide an overview of the application of PET-based radiomics of [

methodsThe most relevant databases were explored using an algorithm constructed based on a combination of terms related to our subject and English-language articles published until October 2021 were considered. Among the 247 identified articles, 19 studies were screened for eligibility and 11 met the criteria, with 4 studies including radiomics analyses.

resultsWe summarized the available literature based on a study of PET volumetric parameters and radiomics. Ten articles provided accurate details about volumetric parameters and their prospective value in tumour assessment. We included the data provided by these articles in a sub-analysis, but could not obtain statistically relevant results. Four publications analyzed the diagnostic potential of radiomics and the possibility of creating precise predictive models, their corresponding quality score being assessed.

conclusionsThe use of PET volumetric parameters and radiomics analysis in patients with [

Indexed as

[18F]FDG PET/CTradiomicsthyroid incidentalomavolumetric parameters

Identifiers

PMID35204561
PMCPMC8870948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.